Impact of a nerve block on recovery after hip surgery
Effects of Pericapsular Nerve Group Block on Postoperative Recovery for Total Hip Arthroplasty
This study is testing if a special nerve block can help people recover better after hip surgery compared to standard care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 40 Years to 85 Years |
| Sex | All |
| Sponsor | Umraniye Education and Research Hospital Government |
| Locations | 1 site (Istanbul, Umraniye) |
| Trial ID | NCT06183528 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effects of a pericapsular nerve group (PENG) block on postoperative recovery in patients undergoing total hip arthroplasty (THA) with spinal anesthesia. A total of 60 patients aged 40-85 are randomly assigned to receive either the PENG block or standard care without it. The study aims to assess postoperative pain levels, opioid usage, mobilization times, and overall hospital stay length. Additionally, it evaluates the impact of the PENG block on perioperative hemodynamics and side effects.
Who should consider this trial
Good fit: Ideal candidates are adults aged 40-85 who are scheduled for total hip arthroplasty and have an ASA classification of 1-3.
Not a fit: Patients under 40 or over 85 years of age, those with cognitive impairments, or ASA classification of 4 and above may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce postoperative pain and opioid dependency for patients undergoing hip surgery.
How similar studies have performed: Previous studies have shown promising results with similar nerve block techniques in reducing postoperative pain, suggesting this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * THA performed by posterior approach * 40-85 age range * ASA 1-3 Exclusion Criteria: Under 40 years of age, over 85 years of age, * ASA 4 and above, * Cognitive impairment (Alzheimer's disease, dementia, delirium etc.), * Hip fracture, * Application site infection, * Allergy to local anaesthetic agents, * Patients are non-consenting patients.
Where this trial is running
Istanbul, Umraniye
- UmraniyeERH — Istanbul, Umraniye, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: zeliha tuncel, ass prof
- Email: zelihalara@yahoo.com
- Phone: +905053577483
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.